Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001013594-25-001271·CG Oncology, Inc.
Schedule 13D ownership disclosure
CG oncology Inc
Common Stock, par value $0.0001 per share · CUSIP: 156944100
Event date: 2025-10-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Seven Fleet Master Fund LP
Shares: 1,515,151 · Class: 1.9%
- Seven Fleet Capital Management LPReported CIK 0002092021
Shares: 1,515,151 · Class: 1.9%
- Seven Fleet Capital Management GP LLC
Shares: 1,515,151 · Class: 1.9%
- Brian Liu
Shares: 1,542,833 · Class: 2.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-25-001271
- Form type
- SCHEDULE 13D/A
- Filer
- CG Oncology, Inc.
- CIK
- CIK 1991792
- Filed
- Oct 28, 2025
- Reporting period
- Oct 06, 2025
- Description
- Schedule 13D beneficial ownership